Alaunos Therapeutics: director Jerman Michael Allen received 20,990 shares

What happened The filing reports that Jerman Michael Allen, a director, received 20,990 shares of common stock as an award (code A) at $0.74 per share, for a total of $15,625. The filing footnote states the shares were issued in lieu of board fees.

Key details

• Transaction date and price: Oct 6, 2026 — 20,990 shares at $0.74 per share, total $15,625.
• Transaction code: A (award/grant).
• Shares owned after the transaction: not stated in the provided filing details.
• Footnote F1: represents shares of common stock issued in lieu of board fees.
• Filing date: Oct 8, 2026; timeliness not indicated in the provided details.

Why it may matter This was an award of shares issued to a director, not a market purchase or sale. A filing does not show why the insider traded or why the company acted.